Status:
UNKNOWN
Cohort Construction for Preterm Infants With Growth Retardation and Its Influencing Factors
Lead Sponsor:
Peking University Third Hospital
Conditions:
Problem With Growth of an Infant
Eligibility:
All Genders
24-37 years
Brief Summary
In this cohort, prospective clinical cohort study was used to establish a follow-up cohort of preterm infants with different gestational ages. The regular monitoring indexes of physical development an...
Detailed Description
Preterm infants are at high risk of stunting due to premature birth, insufficient intrauterine nutrient reserves, burden of various diseases after birth, and persistent nutrient liabilities. The growt...
Eligibility Criteria
Inclusion
- All preterm infants born less than 37 weeks during the study period
Exclusion
- Congenital malformations or genetic diseases Various surgical treatments during the newborn period Interrupted treatment or discharged automatically
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2023
Estimated Enrollment :
2400 Patients enrolled
Trial Details
Trial ID
NCT04817878
Start Date
December 1 2020
End Date
November 30 2023
Last Update
March 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191